Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 100.98M | 52.70M | 77.79M | 123.63M | 66.18M |
Gross Profit | -5.27M | 17.77M | 14.28M | -3.81M | -16.37M |
EBITDA | -49.13M | -33.44M | -86.69M | -74.66M | -331.16M |
Net Income | -80.81M | -38.60M | 43.61M | -62.71M | -356.58M |
Balance Sheet | |||||
Total Assets | 392.46M | 502.83M | 801.34M | 1.08B | 1.19B |
Cash, Cash Equivalents and Short-Term Investments | 16.65M | 32.42M | 194.62M | 183.97M | 327.76M |
Total Debt | 10.29M | 2.31M | 152.65M | 423.69M | 473.39M |
Total Liabilities | 51.58M | 49.89M | 264.68M | 565.75M | 611.10M |
Stockholders Equity | 340.88M | 452.94M | 503.90M | 515.71M | 568.06M |
Cash Flow | |||||
Free Cash Flow | -23.82M | -26.62M | -49.98M | -105.65M | -242.54M |
Operating Cash Flow | -19.58M | -24.96M | -48.24M | -86.16M | -242.00M |
Investing Cash Flow | 3.17M | 18.41M | 77.28M | -40.46M | 235.31M |
Financing Cash Flow | 1.51M | -2.56M | -12.03M | 14.37M | 31.96M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | 1.42B | 3.92 | ― | 7.34% | 1.11% | 3.98% | |
62 Neutral | 360.16M | 12.38 | 1.08% | ― | -9.75% | -81.16% | |
54 Neutral | 118.58M | -13.25 | -1.57% | ― | 135.97% | ― | |
47 Neutral | 151.09M | -18.31 | -46.77% | ― | -5.19% | 36.15% | |
46 Neutral | HK$128.24M | ― | -21.07% | ― | 25.64% | -25.07% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
China Ever Grand Financial Leasing Group Co., Ltd. has announced the termination of a previous agreement for the disposal of Property 103 with Jino Saier and has entered a new agreement with Solarbio for the same property. The new transaction, which is part of a larger set of agreements with Solarbio, is classified as a major transaction under the Listing Rules and requires shareholder approval. This strategic move is expected to impact the company’s financial operations and market positioning, as it involves significant asset disposal and compliance with regulatory requirements.
China Ever Grand Financial Leasing Group Co., Ltd., through its subsidiary Livingzone (Shanghai) Bio-Chem Technology Co., Ltd., has entered into an agreement to sell industrial properties in Shanghai to Shanghai Solarbio Bioscience & Technology Co., Ltd. for RMB35,404,285. This transaction, classified as a major transaction under Hong Kong’s Listing Rules, requires shareholder approval and involves the sale of investment properties with a total gross floor area of approximately 4,165.21 square meters. The disposal is subject to conditions precedent, and shareholders are advised to exercise caution.
China Ever Grand Financial Leasing Group Co., Ltd. reported its unaudited interim results for the six months ending June 30, 2025, showing a decrease in total revenue to HK$39,874,000 from HK$47,023,000 in the same period of 2024. The company faced a loss before taxation of HK$37,653,000, though it saw some improvement in other comprehensive income, which reduced the total comprehensive expense for the period to HK$28,479,000. This financial performance reflects ongoing challenges in the market, impacting the company’s profitability and signaling potential concerns for stakeholders.
China Ever Grand Financial Leasing Group Co., Ltd. has announced that its board of directors will meet on August 21, 2025, to approve the interim results for the first half of the year and consider an interim dividend. This meeting could impact the company’s financial strategy and shareholder returns, reflecting its operational performance and market positioning in the financial leasing sector.
China Ever Grand Financial Leasing Group Co., Ltd. has announced the composition of its board of directors and the roles within its board committees. The board is comprised of executive, non-executive, and independent non-executive directors, with specific members assigned to the audit, remuneration, and nomination committees. This announcement provides clarity on the governance structure of the company, which is crucial for stakeholders and may impact its operational transparency and strategic decision-making.
China Ever Grand Financial Leasing Group Co., Ltd. has outlined the terms of reference for its Nomination Committee, which is responsible for reviewing the board’s structure, diversity, and size, and making recommendations for changes to align with the company’s corporate strategy. The committee’s duties include identifying qualified candidates for board membership, assessing the independence of non-executive directors, and overseeing succession planning and diversity policies. This announcement underscores the company’s commitment to maintaining a diverse and strategically aligned board, which could enhance its governance practices and potentially improve stakeholder confidence.
China Ever Grand Financial Leasing Group Co., Ltd. announced changes to its Nomination Committee, effective June 30, 2025. These changes, which include the appointment of Ms. Yip Man Yi and the redesignation of Mr. Wu Kai Tang as chairman, aim to comply with upcoming amendments to Hong Kong’s Listing Rules and the Corporate Governance Code. The company believes these adjustments will bolster the committee’s effectiveness and diversity, thereby enhancing overall corporate governance practices.
China Ever Grand Financial Leasing Group Co., Ltd. announced the appointment of Mr. Wu Kai Tang and Mr. Ng Kwok Sang as independent non-executive directors. Both appointees have confirmed their independence according to the Listing Rules, with no financial or other interests in the company’s business or connections with core connected persons, ensuring their impartiality in governance.